Yi Liua
Impact in
- Reproductive Medicine top 1%
- Endometriosis Research and Treatment
- Obstetrics and Gynecology top 2%
Papers in
-
- Endometriosis Research and Treatment 25
- Ovarian function and disorders 11
-
- Uterine Myomas and Treatments 8
- Endometrial and Cervical Cancer Treatments 5
- Co-authors
- Xiulan Liu (6 shared papers)Dong Liu (5 shared papers)Lin Qiu (5 shared papers)Pan Luo (3 shared papers)Juan Li (1 shared paper)Wenqian Xiong (28 shared papers)Hengwei Liu (22 shared papers)Yu Du (10 shared papers)
- Journals
- Reproduction (6 papers)Frontiers in Endocrinology (4 papers)Biology of Reproduction (4 papers)The FASEB Journal (3 papers)Journal of Medical Virology (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yi Liua
139 papers receiving 4.4k citations
Yi Liua's Hit Papers
Peers
Comparison fields: 5 of 153
- Reproductive Medicine 700
- Obstetrics and Gynecology 328
- Infectious Diseases 786
- Dermatology 375
- Immunology 774
Countries citing papers authored by Yi Liua
This map shows the geographic impact of Yi Liua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Liua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Liua more than expected).
Fields of papers citing papers by Yi Liua
This network shows the impact of papers produced by Yi Liua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Liua. The network helps show where Yi Liua may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Liua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab treatment in COVID‐19: A single center experience Hit paper breakdown → | 2020 | 997 |
| 2 | Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial Hit paper breakdown → | 2017 | 450 |
| 3 | 2007 | 302 | |
| 4 | 2010 | 139 | |
| 5 | 2017 | 115 | |
| 6 | 2014 | 99 | |
| 7 | 2016 | 88 | |
| 8 | 2017 | 88 | |
| 9 | 2017 | 85 | |
| 10 | 2018 | 78 | |
| 11 | 2020 | 77 | |
| 12 | 2016 | 76 | |
| 13 | 2018 | 63 | |
| 14 | 2018 | 61 | |
| 15 | 2016 | 59 | |
| 16 | 2021 | 56 | |
| 17 | 2019 | 54 | |
| 18 | 2011 | 54 | |
| 19 | 2012 | 52 | |
| 20 | 2015 | 51 |
About Yi Liua
Yi Liua is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Molecular Biology, Immunology and Cancer Research, having authored 154 papers that have together received 4.5k indexed citations. Recurring topics across this work include Endometriosis Research and Treatment (25 papers), Ovarian function and disorders (11 papers), Reproductive System and Pregnancy (8 papers), Uterine Myomas and Treatments (8 papers), Endometrial and Cervical Cancer Treatments (5 papers), RNA modifications and cancer (5 papers), COVID-19 Clinical Research Studies (5 papers) and Pain Mechanisms and Treatments (5 papers). The work is most often cited by research in Reproductive Medicine (700 citations), Obstetrics and Gynecology (328 citations), Infectious Diseases (786 citations), Dermatology (375 citations) and Immunology (774 citations). Yi Liua has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiulan Liu, Dong Liu, Lin Qiu, Pan Luo, Juan Li, Wenqian Xiong, Hengwei Liu, Yu Du, Yao Xiong and Wei Gong. Their work appears in journals such as Reproduction, Frontiers in Endocrinology, Biology of Reproduction, The FASEB Journal and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.